br.osei
Submits third-party assay reports on material purchased directly. Based in Rijeka.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
7
n=7
Annotations
0
n=0
Median purity submitted
98.68%
n=7
Suppliers covered
5
n=7
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-042644 | Semaglutide | SWB | SWB-2602-X7905 | PeptideMeter | 2026-Q3 | 98.76 | 3.57 | 97.7 | Buyer-sourced | 0 | PASS |
| AX-2026-042080 | MOTS-c | HYB | HYB-2606-D7858 | VendorInvestigate | 2026-Q3 | 98.29 | 2.10 | 95.6 | Laboratory-retained | 0 | PASS |
| AX-2026-043402 | MOTS-c | WXT | WXT-2512-K3109 | Medutest | 2026-Q1 | 98.68 | 2.13 | 88.6 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-020007 | Retatrutide | SWB | SWB-2411-R7167 | Nordanalyt | 2025-Q1 | 97.90 | 4.11 | — | Buyer-sourced | 0 | PASS |
| AX-2025-018746 | CJC-1295 (no DAC) | QSC | QSC-2411-D7855 | Janoshik | 2025-Q1 | 99.42 | 3.29 | 89.7 | Buyer-sourced | 1 | MARGINAL |
| AX-2024-005306 | Tirzepatide | BCH | BCH-2404-N5218 | Janoshik | 2024-Q3 | 97.60 | 3.79 | 104.0 | Laboratory-retained | 0 | PASS |
| AX-2024-004297 | Retatrutide | QSC | QSC-2404-P7076 | Janoshik | 2024-Q2 | 98.81 | 6.54 | 105.4 | Buyer-sourced | 0 | PASS |